홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
LYEL
#2840
Lyell Immunopharma, Inc. Common Stock
24.105
0
USD
-2.80%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-2.80%
월간 변동
+12.80%
6달 변화
-0.35%
년간 변동율
-0.35%
이전 종가
24.800
0
Open
24.200
0
Bid
Ask
Low
24.090
0
High
24.270
0
양
8
마켓
주식
헬스케어
LYEL
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
12.27 M
12.48 M
12.7 M
14.76 M
23.31 M
—
Valuation ratios
Enterprise value
1.61 B
715.13 M
390.5 M
83.35 M
657.21 M
987.81 M
Price to earnings ratio
-4.21
-4.54
-2.27
-0.49
-1.92
-3.42
Price to sales ratio
0.1
9.8
4 073.65
2 743.4
14.61 K
24.8 K
Price to cash flow ratio
-0.01
-4.9
-3.24
-1.03
-3.51
-6.49
Price to book ratio
0
1
0.81
0.44
2.12
2.46
EBITDA 비율에 대한 기업 가치
-7.98
-4.23
-1.72
-0.25
-2.55
-3.54
Profitability ratios
Return on assets %
-0.22
-0.2
-0.31
-0.7
-0.81
-0.74
Return on equity %
-0.27
-0.22
-0.36
-0.9
-1.11
-0.98
Return on invested capital %
-127.37
-129.16
-275.12
-562.33
-869.26
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-2 016.68
-220.89
-190.01 K
-588.12 K
-748.34 K
-3.78 M
EBITDA margin %
-1 888.75
-199.61
-174.43 K
-555.94 K
-716.29 K
-3.64 M
Net margin %
-2 349.47
-216.24
-180.49 K
-562.29 K
-762.36 K
-3.88 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
13.4
17.59
16.07
7.06
5.28
30.71
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.08
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-18.58 K
-13.72
-13.04
-12.42
-8.78
-9.49
EBIT per share
-31.6 K
-15.14
-19.68
-27.44
-15.76
-16.58
EBITDA per share
-29.6 K
-13.68
-18.07
-25.94
-15.09
-15.86
Total debt per share
—
—
—
—
—
—
Cash per share
90.62 K
51.82
43.53
28.34
14.46
71.08
Net current asset value per share
92.16 K
52.72
44.2
29.03
15.27
73.26
Tangible book value per share
136.82 K
67.45
52.19
29.28
14.52
75.55
Working capital per share
85.28 K
49.72
41.45
24.92
12.38
63.34
Book value per share
136.82 K
67.45
52.19
29.28
14.52
75.55
뉴스
Lyell Immunopharma Stock (LYEL) Slides Despite Praise from a Top Wall Street Analyst - TipRanks.com
Morning News Wrap-Up 4/10/26: Today’s Biggest Stock Market Stories! - TipRanks.com
Lyell Immunopharma: Strong Early CAR-T Data, And Now A More Measured Bet (NASDAQ:LYEL)
시티즌즈, 라이엘 이뮤노파마 주식 투자의견 ’시장수익률 상회’ 유지
Citizens reiterates Lyell Immunopharma stock rating on trial progress
Avago, Lumentum among market cap stock movers on Monday
Lyell, 5천만 달러 규모의 지분 추가 거래 완료, CFO 임명
Lyell Immunopharma closes $50M equity tranche, names new CFO
시티즌스, 라이엘 이뮤노파마에 ’시장수익률 상회’ 투자의견 제시, 목표가 $34
Citizens initiates Lyell Immunopharma stock at outperform, $34 target
Lyell Immunopharma, Inc. (LYEL) Presents at TD Cowen 46th Annual Health Care Conference Transcript
The Zacks Analyst Blog Mineralys, Lyell, Insmed and Nektar